BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, May 5, 2026
Home » Topics » Briefs » Other news to note

Other news to note
Other news to note RSS Feed RSS

Other news to note for Feb. 28, 2025

Feb. 28, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Biosymetrics, Epimab, Eli Lilly, Hansoh, Ligand, Medigene, Renovaro, Schrödinger, Silence, Verve, Vertex, Zerve.
Read More

Other news to note for Feb. 28, 2025

Feb. 28, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adagio Medical, Devicor Medical, Imaginesoftware, Konica-Minolta, Life Imaging, Lucid, Mammotome, Medimira Merck, Milliporesigma, Neuralcure, Nexalin, Nucleus Genomics, Rapid Micro Biosystems, Shanghai Chartwell Medical, Sirius Medical, Ubie, Venus Concept, Work Medical.
Read More

Other news to note for Feb. 28, 2025

Feb. 28, 2025
Additional early-stage research and drug discovery news in brief, from: Cognition Therapeutics, Inventiva.
Read More

Other news to note for Feb. 27, 2025

Feb. 27, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Allogene, Enodia, Eli Lilly, Foresight, Idorsia, Nxera, Pfizer, Viatris.
Read More

Other news to note for Feb. 27, 2025

Feb. 27, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Boston Scientific, Brainomix, Contura, Cynosure, Dassault Systèmes, Electrocore, Imaginesoftware, Know Labs, Konica Minolta, Life Spine, Lucid, Medtronic, Nanovis, Pavmed, Perimeter Medical Imaging, Spark Biomedical.
Read More

Other news to note for Feb. 27, 2025

Feb. 27, 2025
Additional early-stage research and drug discovery news in brief, from: Immunic, Microbiotica, Telomir, Theralase, Trethera.
Read More

Other news to note for Feb. 26, 2025

Feb. 26, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Carsgen, Eli Lilly, Hyloris, Infex, Kiniksa, Lava, Nimbus, Oncopeptides, Organovo, Redhill, Ucarsgen, Venus.
Read More

Other news to note for Feb. 26, 2025

Feb. 26, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Averto, Bracco, Eyenovia, Lucid, Natera, Sphere Fluidics, Zereau.
Read More

Other news to note for Feb. 25, 2025

Feb. 25, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: GSK, Idrx, Novo Nordisk, OS Therapies.
Read More

Other news to note for Feb. 25, 2025

Feb. 25, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Caredx, Cerevasc, Fujifilm Healthcare, GE Healthcare, Natera.
Read More
Previous 1 2 … 60 61 62 63 64 65 66 67 68 … 1396 1397 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 4, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • Auvelity

    Axsome’s Auvelity cleared for large Alzheimer’s agitation market

    BioWorld
    Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
  • Pancreas

    Sonire starts US study of cancer HIFU after $18M series A

    BioWorld
    Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
  • Xray showing lung cancer on tablet

    How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III

    BioWorld
    Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing